Literature DB >> 22368193

Middle cerebral air embolism after foam sclerotherapy.

C B Asbjornsen1, C D Rogers, B L Russell.   

Abstract

In the recent past, eight cases of transient ischaemic attack or cerebral vascular accident related to foam sclerotherapy have been reported. The following case is reported to add to the world clinical experience and raises the concern that foam sclerotherapy should continue to be evaluated and reported rigorously to establish the incidence of potentially devastating complications. While waiting for clinical studies to further establish best practice in this area of treatment, it may be in our patients' best interests to reserve the option of foaming sclerosants for selected rather than routine cases of venous insufficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22368193     DOI: 10.1258/phleb.2011.011002

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  4 in total

1.  Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Authors:  Dario Carugo; Dyan N Ankrett; Xuefeng Zhao; Xunli Zhang; Martyn Hill; Vincent O'Byrne; James Hoad; Mehreen Arif; David D I Wright; Andrew L Lewis
Journal:  Phlebology       Date:  2015-06-01       Impact factor: 1.740

2.  A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.

Authors:  Kathleen Gibson; Lowell Kabnick
Journal:  Phlebology       Date:  2016-07-09       Impact factor: 1.740

3.  Efficacy and Safety of Balloon-Occluded Retrograde Transvenous Obliteration with Sodium Tetradecyl Sulfate Liquid Sclerotherapy.

Authors:  Il Soo Chang; Sang Woo Park; So Young Kwon; Won Hyeok Choe; Young Koog Cheon; Chan Sup Shim; Tae Yoon Lee; Jeong Han Kim
Journal:  Korean J Radiol       Date:  2016-03-02       Impact factor: 3.500

4.  A multicenter, randomized, placebo-controlled trial of endovenous thermal ablation with or without polidocanol endovenous microfoam treatment in patients with great saphenous vein incompetence and visible varicosities.

Authors:  Michael Vasquez; Antonios P Gasparis
Journal:  Phlebology       Date:  2016-03-07       Impact factor: 1.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.